James J D Hsieh

Title: The Innovations of James J D Hsieh

Introduction

James J D Hsieh is a notable inventor based in Ladue, MO (US). He has made significant contributions to the field of protease research, particularly with his work on Taspase1. His innovative approach has implications for cancer treatment, especially in leukemia.

Latest Patents

James J D Hsieh holds a patent for "Inhibitors of Taspase1 protease activity." This patent describes a novel protease, Taspase1, which plays a crucial role in the cleavage of the myeloid/lymphoid or mixed-lineage leukemia (MLL) protein. The proper regulation of HOX genes is dependent on this process. The patent also outlines diagnostic methods utilizing Taspase1, as well as inhibitors that can be used to treat cancers, including leukemia, in affected subjects. He has 1 patent to his name.

Career Highlights

Hsieh's career is marked by his dedication to cancer research. His work at the Dana-Farber Cancer Institute Inc. has positioned him as a key figure in the study of protease inhibitors. His research has the potential to lead to new therapeutic strategies for treating leukemia.

Collaborations

James J D Hsieh has collaborated with notable colleagues, including Stanley J Korsmeyer and Susan Korsmeyer, who serves as a Legal Representative. These collaborations have enriched his research and contributed to advancements in the field.

Conclusion

James J D Hsieh's innovative work on Taspase1 inhibitors showcases his commitment to advancing cancer treatment. His contributions are vital in the ongoing battle against leukemia and highlight the importance of research in developing effective therapies.